{"product_id":"united-states-non-invasive-prenatal-testingnipt-market-size-market-share-insights-growth-trends-opportunities-key-players-competitive-analysis-and-forecast-2023-to-2031","title":"United States Non Invasive Prenatal Testing(NIPT) Market Size, Market Share, Insights, Growth, Trends, Opportunities, Key Players, Competitive Analysis and Forecast 2023 to 2031","description":"\u003cp\u003eUnited States Non Invasive Prenatal Testing(NIPT) Market Size, Market Share, Insights, Growth, Trends, Opportunities, Key Players, Competitive Analysis and Forecast 2023 to 2031\u003cbr\u003e\nThe non-invasive prenatal testing (NIPT) market in the United States is expected to reach USD 2,653 million by 2031. The market is expected to register a CAGR of more than 13% in the forecast period.\u003c\/p\u003e\n\n\u003cp\u003eThe growth of the market depends on several factors, including the increase in the incidence of chromosomal aneuploidies in fetuses, the progress of advanced non-invasive prenatal testing products, the increasing acceptance of non-invasive prenatal testing, the growing focus on reimbursement for non-invasive prenatal testing, the rising preference for non-invasive techniques over invasive methods, and the ACOG guidelines recommending NIPT for all pregnancies regardless of risk.\u003c\/p\u003e\n\n\u003cp\u003eThe report on the non-invasive prenatal testing (NIPT) market in the United States is a comprehensive study and presentation of drivers, restraints, opportunities, demand, market size, insights, forecasts, and trends in the non-invasive prenatal testing (NIPT) market in the United States during 2019 - 2031. Furthermore, the report includes historic market data from 2019 to 2022 and forecast until 2031.\u003c\/p\u003e\n\n\u003cp\u003eThis Well-Versed and Comprehensive United States Non-Invasive Prenatal Testing (NIPT) Market Research Report 2023 is Divided into 14 Chapters:\u003c\/p\u003e\n\n\u003cp\u003eChapter 1 contains a brief description of the market under study\u003cbr\u003e\nChapter 2 describes the research methodology of the study\u003cbr\u003e\nChapter 3 identifies key trends and prospects for the U.S. non-invasive prenatal testing (NIPT) market and draws key conclusions\u003cbr\u003e\nChapter 4 analysis of average risk and high-risk non–invasive prenatal testing volume (number of tests performed) and projection through 2031\u003cbr\u003e\nChapter 5 evaluates the potential number of NIPT tests performed in the United States with eight years forecast\u003cbr\u003e\nChapter 6 discusses the market scenario for non-invasive prenatal testing (NIPT) in the United States in terms of historical market values and projections through 2031\u003cbr\u003e\nChapter 7 assessment of market potential and opportunities for this innovation-driven united states non–invasive prenatal testing market with eight years forecast\u003cbr\u003e\nChapter 8 highlights key market dynamics in the U.S. NIPT tests market, including factors driving the market, prevailing barriers, potential opportunities, and future trends. This section also includes an analysis of the impact of the driving and restraining factors\u003cbr\u003e\nChapter 9 includes a comprehensive analysis of 7 non–invasive prenatal testing comparative analysis \u003cbr\u003e\nChapter 10 characteristics of reimbursement structures in the non–invasive prenatal testing market in the United States\u003cbr\u003e\nChapter 11 detailed insights into the regulatory framework of the U.S. non–invasive prenatal testing market\u003cbr\u003e\nChapter 12 tracks competitive developments, approaches, recent industry developments, and mergers and acquisitions, collaboration, venture capital investment, distribution, exclusivity, partnership and licensing agreements.\u003cbr\u003e\nChapter 13 provides the industry landscape and detailed profiles of key companies operating in the non–invasive prenatal testing market in the United States. The companies have been profiled based on their key facts, business description, products and services, current NIPT test portfolio, and key developments.\u003cbr\u003e\nChapter 14 i.e. the appendix contains a brief overview of the company, a glossary, contact information, and the disclaimer section.\u003c\/p\u003e\n\n\u003cp\u003eKey Players in the United States Non–Invasive Prenatal Testing Market are Listed Below:\u003cbr\u003e\nIllumina, Inc.\u003cbr\u003e\nNatera, Inc.\u003cbr\u003e\nQuest Diagnostics\u003cbr\u003e\nMyriad Genetics, Inc.\u003cbr\u003e\nCentogene\u003cbr\u003e\nGenPath\u003cbr\u003e\nPerkinElmer\u003cbr\u003e\nYourgene Health\u003cbr\u003e\nInvitae Corporation\u003cbr\u003e\nAgilent Technologies\u003cbr\u003e\nAriosa Diagnostics (Roche)\u003cbr\u003e\nLaboratory Corporation of America Holdings(Labcorp)\u003c\/p\u003e\n\n\u003cp\u003eThe Most Important Questions are Answered in this Current 2023 Report:\u003c\/p\u003e\n\n\u003cp\u003eWhat is the current scenario of the non-invasive prenatal testing market in the United States?\u003cbr\u003e\nWhat is the total market size for non-invasive prenatal testing in the United States and what are the projections (through 2031) for this market?\u003cbr\u003e\nHow large is the market for noninvasive prenatal testing in the United States?\u003cbr\u003e\nWhich is the top non-invasive prenatal test available in the united states?\u003cbr\u003e\nHow has the potential market performed so far and how will it perform in the coming years?\u003cbr\u003e\nHow many NIPT tests are being performed in the united states during 2019 – 2031?\u003cbr\u003e\nWhat is the market size of the average risk NIPT tests in the united states?\u003cbr\u003e\nWhat is the market size of the high-risk NIPT tests in the united states?\u003cbr\u003e\nWhat are the key marketed NIPT tests available in the united states?\u003cbr\u003e\nWhat are the major drivers of the united states non–invasive prenatal testing market?\u003cbr\u003e\nWhat are the major inhibitors of the united states non–invasive prenatal testing market?\u003cbr\u003e\nWhat is the reimbursement pattern in the united states non–invasive prenatal testing market?\u003cbr\u003e\nWhat is the regulatory framework in the united states non–invasive prenatal testing market?\u003cbr\u003e\nWhat are the major deals and agreement happenings in the united states non–invasive prenatal testing market?\u003cbr\u003e\nWhat companies offer NIPT tests in the united states?\u003cbr\u003e\nWho are the top market players? What are their happenings, current developments, and scenarios?\u003cbr\u003e\nHow is the market predicted to develop in the future?\u003cbr\u003e\nWhat is the degree of competition in the industry?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"June, 2023 \/ 150 Pages \/ MCW16236944","offer_id":47652338794802,"sku":null,"price":2388.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/united-states-non-invasive-prenatal-testingnipt-market-size-market-share-insights-growth-trends-opportunities-key-players-competitive-analysis-and-forecast-2023-to-2031","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}